Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Veru Inc sell BiotechBee

Start price
€11.67
07.09.22 / 60%
Target price
€7.00
31.12.24
Performance (%)
-38.34%
End price
€7.20
11.11.22
Summary
This prediction ended on 11.11.22 with a price of €7.20. BiotechBee correctly predicted massive losses of -38.34% for Veru Inc. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Veru Inc 17.413% 17.413% -45.387%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to BiotechBee what are the pros and cons of Veru Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Veru Inc diskutieren
Prediction Sell
Perf. (%) -38.34%
Target price 7.000
Change
Ends at 31.12.24

Sell mit Kursziel 7,0

In the thread Trading Veru Inc
Prediction Sell
Perf. (%) -38.34%
Target price 7.000
Change
Ends at 31.12.24

Sell beendet